RiseHealth Compass’ Post

💡 As medical communicators, we transform data into meaningful stories. This is how we take things like statistical health disparities and give them a face and personality. That's why I'm really looking forward to this breakout session at the upcoming Healthcare Businesswomen’s Association Annual Conference #HBAAC24: 💖 Health Equity by the Numbers: Bridging Data and Human Experience At Med Ink Consulting, many of our projects incorporate #HealthEquity. We help pharmaceutical companies engage with patient communities to help ensure their needs are being met. #Conferences #ProfessionalDevelopment

FasterCures’ director, Hadly Clark, MHSA, was featured in the Pfizer Specialty Voices of Innovation series. Hadly sat down with Kevin Sullivan, Pfizer's US Specialty Care President, to discuss how health systems can prepare to provide patients with groundbreaking, innovative treatments.   Watch their full conversation here: https://lnkd.in/g2TygdbX

In Chapter 2 of our Pfizer Specialty Voices of Innovation series, Kevin Sullivan, US Specialty Care President at Pfizer, sits down with Hadly Clark, MHSA, Director at the Milken Institute’s FasterCures, to discuss how industry partners can work together to advance a more equitable healthcare system. Watch the rest of Kevin and Hadly’s conversation here: https://lnkd.in/eDa6xeEh #VoicesofInnovation #MilkenInstitute #MedicalAdvancements #AccessToCare

During the 𝗚𝗲𝗻𝗦𝗰𝗿𝗶𝗽𝘁 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗚𝗹𝗼𝗯𝗮𝗹 𝗙𝗼𝗿𝘂𝗺 in London, Dr. James Wilson, President & CEO of Gemma Biotherapeutics, delivered an inspiring keynote speech. He explored the challenges of commercialization, technological hurdles, and the complexities of clinical trials and manufacturing. Dr. Wilson emphasized the pivotal role of 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗮𝗱𝘃𝗼𝗰𝗮𝗰𝘆 and 𝘀𝗼𝗰𝗶𝗮𝗹 𝗺𝗲𝗱𝗶𝗮 in raising awareness and improving drug accessibility. He also addressed the need for efficient 𝗿𝗲𝗶𝗺𝗯𝘂𝗿𝘀𝗲𝗺𝗲𝗻𝘁 𝗺𝗲𝗰𝗵𝗮𝗻𝗶𝘀𝗺𝘀 to balance innovation and healthcare resource utilization. Learn more: https://lnkd.in/eXYqSSjY #CGT #DrugAccessibility #Innovation #HealthcareInnovation #GeneEditing #LondonEvent #HealthTech #HealthcareEventsUK

🚀 The healthcare of tomorrow is being developed today at Medcare Pharma. We're pioneering solutions for conditions that have long challenged the medical community. 🌟 As a trial participant, you'll have access to potential treatments years before they reach the general public. Your experience could help refine therapies that change lives. Ready to step into the future of healthcare? Contact us to explore our cutting-edge research opportunities! 🩺 Medcare Pharma: Your Way to Cure Contact us: ☎️ | 1-866-4-MEDICINE 📧 | info@medcarepharma.care 🌐 | https://lnkd.in/gA9pPUVR #HealthcareInnovation #ResearchOpportunities #FutureOfMedicine #HealthTech #PatientCare #TransformingLives #JoinUs #clinicaltrial #clinicalresearch #medicalresearch #clinicalstudies #clinicalstudy #healthcare #medcarepharma #researchstudies

The Clarivate Life Sciences & Healthcare Consulting team recently hosted a pivotal roundtable, bringing together industry leaders and representatives from pharmaceutical companies and trade associations to discuss strategies and solutions for overcoming barriers to innovative therapies. A special thank you to our esteemed speakers: Ken Walsh, Sophie Doran, and Laurie DiModica for their insights on Optimising Access. Alison Isherwood for her impactful presentation on Reducing Disparities and Health Inequity. Sarah Knight and Helen Kitchen for leading the discussion on Driving Patient Outcomes. Jasmine Carlson and Gaia G. for sharing compelling data and insights that reinforced our key findings. Download the whitepaper to explore key highlights from the discussion on succeeding with advanced therapies in Europe. Discover strategies to enhance patient access, reduce health inequality, and drive patient outcomes, here: https://lnkd.in/ejTdfqKN #PatientCare #Pharma #LifeSciences #Healthcare #Innovation #AdvancedTherapies #PatientAccess #HealthEquity

Jean McCoy, EVP Partnerships shares her thoughtful insights on the value of incorporating the patient voice earlier in the clinical trial recruitment process. Read more for practical tips on how to make this a reality for your next project. https://bit.ly/3IhvEob #clinicaltrialrecruitment #patientvoice 

Marijn Verhoef, the Foundation's Director of Operations & Government Engagement, is speaking today at the second workshop of a three-part series hosted by the Bill & Melinda Gates Foundation in Berlin. The workshop, titled "Towards Harmonizing Access and Impact Measures", will explore ways to broaden how #pharma companies measure the number of patients reached through their access efforts. Marijn will participate in a panel discussion on "Double Materiality of Access", where he will share findings from our recent report and discuss how companies are measuring and reporting the number of patients reached with their essential products. Learn more ➡ https://lnkd.in/esQ8YgYB #AccesstoMedicine #EquitableAccess #AccesstoHealthcare #HealthEquity #GlobalHealth

Gone are the days of passive patient care. With Patient-Reported Outcomes, individuals are now active participants in their healthcare journey, writes Sciensus CMO Richard Blyth. But, how can we unleash these invaluable insights to drive better outcomes for both patients and pharma? Check out the full piece below to find out. #PatientEngagement #Pharma #DigitalHealth https://lnkd.in/epiWd2rQ

Building successful drug market access strategies has a lot to do with data and tactics, but those are far from being the only things—it's about fostering trust and chemistry with vendors and partners. Strong relationships drive collaboration, innovation, and ultimately, better patient access to life-changing therapies. We don't see enough of these strong relationships nowadays, but when we do, real progress happens. #MarketAccess #Healthcare #DrugAccess